Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2019

Apr 30, 2019

30786_dirs_2019-04-30_234464d9-08aa-4cc8-b2ea-a264b6f267a3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2019-04-29

Reporting Person: Last Andrew J. (EVP, Chief Operating Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-04-29 Restricted Stock Units $0 A 5000 Acquired Bio-Rad A Common Stock (5000) Direct
2019-04-29 Non-Qualified Stock Option (right to buy) $299.24 A 5000 Acquired 2029-04-29 Bio-Rad A Common Stock (5000) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F2: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.

F3: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.